Up-regulation of PPARγ coactivator-1α as a strategy for preventing and reversing insulin resistance and obesity
- 1 January 2005
- journal article
- Published by Elsevier in Medical Hypotheses
- Vol. 64 (2) , 399-407
- https://doi.org/10.1016/j.mehy.2004.03.034
Abstract
No abstract availableKeywords
This publication has 108 references indexed in Scilit:
- PGC-1α-responsive genes involved in oxidative phosphorylation are coordinately downregulated in human diabetesNature Genetics, 2003
- The chlorophyll-derived metabolite phytanic acid induces white adipocyte differentiationInternational Journal of Obesity, 2002
- Role of AMP-activated protein kinase in mechanism of metformin actionJournal of Clinical Investigation, 2001
- Activation of PPARδ alters lipid metabolism in db/db miceFEBS Letters, 2000
- High-dose biotin, an inducer of glucokinase expression, may synergize with chromium picolinate to enable a definitive nutritional therapy for type II diabetesMedical Hypotheses, 1999
- AMP‐activated protein kinase phosphorylation of endothelial NO synthaseFEBS Letters, 1999
- Inhibition of lipolysis and lipogenesis in isolated rat adipocytes with AICAR, a cell‐permeable activator of AMP‐activated protein kinaseFEBS Letters, 1994
- Comparative Tolerability Profiles of Oral Antidiabetic AgentsDrug Safety, 1994
- Biotin supplementation improves glucose and insulin tolerances in genetically diabetic KK miceLife Sciences, 1988
- Biotin Enhances Guanylate Cyclase ActivityScience, 1982